Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.

Area of Science:

• Molecular Biology
• Biochemistry
• Microbial Genetics

Background:

• Anti-CRISPR proteins are phage-encoded inhibitors of bacterial CRISPR-Cas adaptive immunity systems.
• Investigating anti-CRISPR diversity provides insights into CRISPR-Cas mechanisms and potential biotechnological applications.

Purpose of the Study:

• To determine the solution structure and mechanism of AcrIE2, an inhibitor of the type I-E CRISPR-Cas system from Pseudomonas aeruginosa.
• To elucidate how AcrIE2 interacts with the type I-E CRISPR-Cas Cascade complex and affects its function.

Main Methods:

• Nuclear Magnetic Resonance (NMR) spectroscopy for solution structure determination.
• Site-directed mutagenesis to identify functional residues.
• Affinity purification to assess protein-protein interactions.
• In vivo transcriptional assays to evaluate DNA-binding and regulatory effects.

Main Results:

• The solution structure of AcrIE2 was determined, revealing its interaction with the type I-E CRISPR-Cas Cascade complex.
• AcrIE2 binding to Cascade does not prevent DNA binding to promoter regions.
• Cascade:AcrIE2 complex binding can lead to transcriptional activation, a novel mechanism for type I anti-CRISPRs.
• AcrIE2 likely inhibits DNA cleavage by preventing Cas3 nuclease recruitment, not DNA binding.

Conclusions:

• AcrIE2 employs a distinct inhibitory mechanism compared to previously characterized type I anti-CRISPRs.
• This study reveals a novel anti-CRISPR function involving transcriptional activation and differential effects on DNA binding.
• AcrIE2 represents a unique tool for dissecting type I CRISPR-Cas system regulation and function.